Cargando…

Does the interval from tumour surgery to radiotherapy influence survival in paediatric high grade glioma?

PURPOSE: Paediatric high grade glioma (pHGG) are rare. Following maximum safe resection, children >3 years with HGG receive radiotherapy as standard of care. Whether the interval from tumour surgery to radiotherapy (ISRT) influences survival is disputed in adults with glioblastoma, data for child...

Descripción completa

Detalles Bibliográficos
Autores principales:	Azizi, Amedeo A., Paur, Simon, Kaider, Alexandra, Dieckmann, Karin, Peyrl, Andreas, Chocholous, Monika, Czech, Thomas, Slavc, Irene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959993/ https://www.ncbi.nlm.nih.gov/pubmed/29349602 http://dx.doi.org/10.1007/s00066-018-1260-z

Ejemplares similares

Atypical teratoid rhabdoid tumor: improved long-term survival with an intensive multimodal therapy and delayed radiotherapy. The Medical University of Vienna Experience 1992–2012
por: Slavc, Irene, et al.
Publicado: (2014)

ETMR-10. EARLY FOCAL RADIOTHERAPY AND TEMOZOLOMIDE FOLLOWING COMPLETE RESECTION APPEAR SUPERIOR TO INTENSIVE CHEMOTHERAPY AND DELAYED RADIOTHERAPY IN CHILDREN WITH EMBRYONAL TUMORS WITH MULTILAYERED ROSETTES (ETMR)
por: Mayr, Lisa, et al.
Publicado: (2020)

Infiltrative gliomas of the thalamus in children: the role of surgery in the era of H3 K27M mutant midline gliomas
por: Dorfer, Christian, et al.
Publicado: (2020)

HGG-44. DEFECTS OF MISMATCH REPAIR PROTEINS IN PEDIATRIC HIGH GRADE GLIOMAS
por: Haberler, Christine, et al.
Publicado: (2020)

Potential Importance of Early Focal Radiotherapy Following Gross Total Resection for Long-Term Survival in Children With Embryonal Tumors With Multilayered Rosettes
por: Mayr, Lisa, et al.
Publicado: (2020)

Improved Long-Term Survival of Patients with Recurrent Medulloblastoma Treated with a “MEMMAT-like” Metronomic Antiangiogenic Approach
por: Slavc, Irene, et al.
Publicado: (2022)

Sociocultural variables have a major impact on participation in patients treated for paediatric posterior fossa tumours
por: Hoffmann‐Lamplmair, Doris, et al.
Publicado: (2022)

Prospective Evaluation of Kidney Function in Long-Term Survivors of Pediatric CNS Tumors
por: Stepien, Natalia, et al.
Publicado: (2022)

Placement of EVD in pediatric posterior fossa tumors: safe and efficient or old-fashioned? The Vienna experience
por: Hedrich, Cora, et al.
Publicado: (2023)

DDEL-03. LONG-TERM INTRAVENTRICULAR THERAPY ALTERNATING ETOPOSIDE AND LIPOSOMAL CYTARABINE: EXPERIENCE IN 75 CHILDREN AND ADOLESCENTS WITH MALIGNANT BRAIN TUMORS
por: Stepien, Natalia, et al.
Publicado: (2020)

RARE-20. A RARE CASE OF A PRIMARY CENTRAL NERVOUS SYSTEM NEUROENDOCRINE CARCINOMA AND SUCCESSFULL THERAPY IN A FIVE-YEAR-OLD CHILD
por: Stepien, Natalia, et al.
Publicado: (2021)

Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma
por: Araki, Asuka, et al.
Publicado: (2016)

Personalized Treatment of H3K27M-Mutant Pediatric Diffuse Gliomas Provides Improved Therapeutic Opportunities
por: Gojo, Johannes, et al.
Publicado: (2020)

Cerebrospinal Fluid Penetration and Combination Therapy of Entrectinib for Disseminated ROS1/NTRK-Fusion Positive Pediatric High-Grade Glioma
por: Mayr, Lisa, et al.
Publicado: (2020)

Cerebellar pilocytic astrocytoma in childhood: Investigating the long-term impact of surgery on cognitive performance and functional outcome
por: Pletschko, Thomas, et al.
Publicado: (2017)

Unique Finding of a Primary Central Nervous System Neuroendocrine Carcinoma in a 5-Year-Old Child: A Case Report
por: Stepien, Natalia, et al.
Publicado: (2022)

HGG-50. Specific sensitivity of pediatric high-grade glioma with ATRX inactivation to PARP inhibitor combinations
por: Laemmerer, Anna, et al.
Publicado: (2022)

DDEL-05. Intraventricular therapy with topotecan is feasible and safe: Experience in 50 pediatric patients with various malignant brain tumors
por: Peyrl, Andreas, et al.
Publicado: (2022)

Evaluating the diagnostic validity of the cerebellar cognitive affective syndrome (CCAS) in pediatric posterior fossa tumor patients
por: Hoffmann-Lamplmair, Doris, et al.
Publicado: (2022)

TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAF(V600E)/TERT promoter double-mutated glioma
por: Gabler, Lisa, et al.
Publicado: (2019)

Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled Trial
por: Peyrl, Andreas, et al.
Publicado: (2023)

Management of choroid plexus tumors—an institutional experience
por: Hosmann, Arthur, et al.
Publicado: (2019)

MBCL-43. RECURRENT MEDULLOBLASTOMA – LONG-TERM SURVIVAL WITH A “MEMMAT” BASED ANTIANGIOGENIC APPROACH
por: Slavc, Irene, et al.
Publicado: (2020)

Radiotherapy in high grade gliomas
por: Bleehen, N.M., et al.
Publicado: (1989)

IMG-03. Impact of childhood cerebellar tumor surgery on cognition: Can fMRI serve as a surrogate marker?
por: Dorfer, Christian, et al.
Publicado: (2022)

SURG-02. The site of origin of medulloblastoma: Does the neurosurgical perspective support the current concept from molecular data?
por: Ciobanu-Caraus, Olga, et al.
Publicado: (2022)

Neuronal correlates of cognitive function in patients with childhood cerebellar tumor lesions
por: Reichert, Johanna L., et al.
Publicado: (2017)

Impact of childhood cerebellar tumor surgery on cognition revealed by precuneus hyperconnectivity
por: Dorfer, Christian, et al.
Publicado: (2022)

Pharmacokinetics of Bevacizumab in Three Patients Under the Age of 3 Years with CNS Malignancies
por: Gojo, Johannes, et al.
Publicado: (2017)

PAEDIATRIC-12 MANAGEMENT OF PAEDIATRIC LOW-GRADE GLIOMA IN CAPE TOWN, SOUTH AFRICA
por: Tsimane, Katlego, et al.
Publicado: (2023)

Back to the future--radiotherapy in high grade gliomas.
por: Brada, M.
Publicado: (1989)

Paediatric-type diffuse low-grade gliomas: a clinically and biologically distinct group of tumours with a favourable outcome
por: Fabbri, Viscardo Paolo, et al.
Publicado: (2022)

LGG-57. SIGNALLING MECHANISMS IN PAEDIATRIC LOW-GRADE GLIOMA
por: Patel, Ankit, et al.
Publicado: (2020)

Multifocal high-grade glioma radiotherapy safety and efficacy
por: Fleischmann, Daniel Felix, et al.
Publicado: (2021)

Predicting regrowth of low-grade gliomas after radiotherapy
por: Plaszczynski, Stéphane, et al.
Publicado: (2023)

Temozolomide in paediatric high-grade glioma: a key for combination therapy?
por: Verschuur, A C, et al.
Publicado: (2004)

Alternative lengthening of telomeres in molecular subgroups of paediatric high-grade glioma
por: Minasi, Simone, et al.
Publicado: (2020)

Orthotopic Transplantation of Human Paediatric High-Grade Glioma in Zebrafish Larvae
por: Larsson, Susanna, et al.
Publicado: (2022)

QOL-30. Positive Effects of a psychological preparation program for MRI in children with cognitive issues – how to best meet the patients’ needs
por: Weiler-Wichtl, Liesa Josephine, et al.
Publicado: (2022)

LGG-09. SENOLYTIC AGENT NAVITOCLAX TARGETS VINBLASTINE- AND MAPK INHIBITORS-INDUCED SENESCENT TUMOUR CELLS IN PAEDIATRIC LOW GRADE GLIOMAS
por: Guiho, Romain, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j8jumn0d709la8lmj0bf754fk7